Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 75

1.

Genome-wide meta-analysis of cerebral white matter hyperintensities in patients with stroke.

Traylor M, Zhang CR, Adib-Samii P, Devan WJ, Parsons OE, Lanfranconi S, Gregory S, Cloonan L, Falcone GJ, Radmanesh F, Fitzpatrick K, Kanakis A, Barrick TR, Moynihan B, Lewis CM, Boncoraglio GB, Lemmens R, Thijs V, Sudlow C, Wardlaw J, Rothwell PM, Meschia JF, Worrall BB, Levi C, Bevan S, Furie KL, Dichgans M, Rosand J, Markus HS, Rost N; International Stroke Genetics Consortium.

Neurology. 2016 Jan 12;86(2):146-53. doi: 10.1212/WNL.0000000000002263. Epub 2015 Dec 16.

2.

[Unconsciousness].

Kallela M, Häppölä O, Eriksson H.

Duodecim. 2014;130(4):368-82. Review. Finnish.

PMID:
24673006
3.

Body temperature, blood infection parameters, and outcome of thrombolysis-treated ischemic stroke patients.

Tiainen M, Meretoja A, Strbian D, Suvanto J, Curtze S, Lindsberg PJ, Soinne L, Tatlisumak T; Helsinki Stroke Thrombolysis Registry Group.

Int J Stroke. 2013 Dec;8(8):632-8. doi: 10.1111/ijs.12039. Epub 2013 Apr 17.

PMID:
23590464
4.

Outcome of ischemic stroke patients with serious post-thrombolysis neurological deficits.

Strbian D, Atula S, Meretoja A, Kaste M, Tatlisumak T; Helsinki Stroke Thrombolysis Registry Group.

Acta Neurol Scand. 2013 Apr;127(4):221-6. doi: 10.1111/j.1600-0404.2012.01698.x. Epub 2012 Jul 4.

PMID:
22762436
5.

Intravenous thrombolysis for acute ischemic stroke patients presenting with mild symptoms.

Strbian D, Piironen K, Meretoja A, Sairanen T, Putaala J, Tiainen M, Artto V, Rantanen K, Häppölä O, Kaste M, Lindsberg PJ; Helsinki Stroke Thrombolysis Registry Group.

Int J Stroke. 2013 Jul;8(5):293-9. doi: 10.1111/j.1747-4949.2012.00808.x. Epub 2012 May 9.

PMID:
22568877
6.

Hemiplegia and thrombolysis.

Meretoja A, Strbian D, Putaala J, Kaste M, Tatlisumak T; Helsinki Stroke Thrombolysis Registry Group.

Eur J Neurol. 2012 Sep;19(9):1235-8. doi: 10.1111/j.1468-1331.2012.03729.x. Epub 2012 Apr 23.

PMID:
22519602
7.

Does time of day or physician experience affect outcome of acute ischemic stroke patients treated with thrombolysis? A study from Finland.

Helsinki Stroke Thrombolysis Registry Group.

Int J Stroke. 2012 Aug;7(6):511-6. doi: 10.1111/j.1747-4949.2012.00795.x. Epub 2012 Apr 12.

PMID:
22494345
8.

Dronedarone in high-risk permanent atrial fibrillation.

Connolly SJ, Camm AJ, Halperin JL, Joyner C, Alings M, Amerena J, Atar D, Avezum Á, Blomström P, Borggrefe M, Budaj A, Chen SA, Ching CK, Commerford P, Dans A, Davy JM, Delacrétaz E, Di Pasquale G, Diaz R, Dorian P, Flaker G, Golitsyn S, Gonzalez-Hermosillo A, Granger CB, Heidbüchel H, Kautzner J, Kim JS, Lanas F, Lewis BS, Merino JL, Morillo C, Murin J, Narasimhan C, Paolasso E, Parkhomenko A, Peters NS, Sim KH, Stiles MK, Tanomsup S, Toivonen L, Tomcsányi J, Torp-Pedersen C, Tse HF, Vardas P, Vinereanu D, Xavier D, Zhu J, Zhu JR, Baret-Cormel L, Weinling E, Staiger C, Yusuf S, Chrolavicius S, Afzal R, Hohnloser SH; PALLAS Investigators.

N Engl J Med. 2011 Dec 15;365(24):2268-76. doi: 10.1056/NEJMoa1109867. Epub 2011 Nov 14. Erratum in: N Engl J Med. 2012 Feb 16;366(7):672.

9.

Stroke mimics and intravenous thrombolysis.

Artto V, Putaala J, Strbian D, Meretoja A, Piironen K, Liebkind R, Silvennoinen H, Atula S, Häppölä O; Helsinki Stroke Thrombolysis Registry Group.

Ann Emerg Med. 2012 Jan;59(1):27-32. doi: 10.1016/j.annemergmed.2011.09.011. Epub 2011 Oct 14.

PMID:
22000770
10.

A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS.

Freedman MS, Bar-Or A, Oger J, Traboulsee A, Patry D, Young C, Olsson T, Li D, Hartung HP, Krantz M, Ferenczi L, Verco T; MAESTRO-01 Investigators.

Neurology. 2011 Oct 18;77(16):1551-60. doi: 10.1212/WNL.0b013e318233b240. Epub 2011 Oct 5.

PMID:
21975206
11.

Intravenous thrombolysis of basilar artery occlusion: predictors of recanalization and outcome.

Sairanen T, Strbian D, Soinne L, Silvennoinen H, Salonen O, Artto V, Koskela I, Häppölä O, Kaste M, Lindsberg PJ; Helsinki Stroke Thrombolysis Registry (HSTR) Group.

Stroke. 2011 Aug;42(8):2175-9. doi: 10.1161/STROKEAHA.110.605584. Epub 2011 Jul 7.

12.

Strict glucose control after acute stroke can be provided in the prehospital setting.

Nurmi J, Lindsberg PJ, Häppölä O, Klemetti E, Westerbacka J, Castrén M.

Acad Emerg Med. 2011 Apr;18(4):436-9. doi: 10.1111/j.1553-2712.2011.01020.x.

13.

[Update on current care guidelines: cerebral infarction (stroke)].

Suomalaisen Lääkäriseuran Duodecimin; Suomen Neurologinen Yhdistys ry:n Asettama Työryhmä.

Duodecim. 2011;127(5):500-1. Review. Finnish.

PMID:
21491756
14.

Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial.

Jolly SS, Yusuf S, Cairns J, Niemelä K, Xavier D, Widimsky P, Budaj A, Niemelä M, Valentin V, Lewis BS, Avezum A, Steg PG, Rao SV, Gao P, Afzal R, Joyner CD, Chrolavicius S, Mehta SR; RIVAL trial group.

Lancet. 2011 Apr 23;377(9775):1409-20. doi: 10.1016/S0140-6736(11)60404-2. Epub 2011 Apr 4. Erratum in: Lancet. 2011 Apr 23;377(9775):1408. Lancet. 2011 Jul 2;378(9785):30.

PMID:
21470671
15.

Irbesartan in patients with atrial fibrillation.

ACTIVE I Investigators, Yusuf S, Healey JS, Pogue J, Chrolavicius S, Flather M, Hart RG, Hohnloser SH, Joyner CD, Pfeffer MA, Connolly SJ.

N Engl J Med. 2011 Mar 10;364(10):928-38. doi: 10.1056/NEJMoa1008816.

16.

Outcome by stroke etiology in patients receiving thrombolytic treatment: descriptive subtype analysis.

Mustanoja S, Meretoja A, Putaala J, Viitanen V, Curtze S, Atula S, Artto V, Häppölä O, Kaste M; Helsinki Stroke Thrombolysis Registry Group.

Stroke. 2011 Jan;42(1):102-6. doi: 10.1161/STROKEAHA.110.597534. Epub 2010 Nov 24.

17.

Post-thrombolytic hyperglycemia and 3-month outcome in acute ischemic stroke.

Putaala J, Sairanen T, Meretoja A, Lindsberg PJ, Tiainen M, Liebkind R, Strbian D, Atula S, Artto V, Rantanen K, Silvonen P, Piironen K, Curtze S, Häppölä O, Mustanoja S, Pitkäniemi J, Salonen O, Silvennoinen H, Soinne L, Kuisma M, Tatlisumak T, Kaste M.

Cerebrovasc Dis. 2011;31(1):83-92. doi: 10.1159/000321332. Epub 2010 Nov 16.

PMID:
21079397
18.

Characteristics and outcome of ischemic stroke patients who are free of symptoms at 24 hours following thrombolysis.

Strbian D, Sairanen T, Rantanen K, Piironen K, Atula S, Tatlisumak T, Soinne L; Helsinki Stroke Thrombolysis Registry Group.

Cerebrovasc Dis. 2011;31(1):37-42. doi: 10.1159/000320263. Epub 2010 Oct 28.

PMID:
20980752
19.

Sequential analysis of pretreatment delays in stroke thrombolysis.

Puolakka T, Väyrynen T, Häppölä O, Soinne L, Kuisma M, Lindsberg PJ.

Acad Emerg Med. 2010 Sep;17(9):965-9. doi: 10.1111/j.1553-2712.2010.00828.x.

20.

Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.

CURRENT-OASIS 7 Investigators, Mehta SR, Bassand JP, Chrolavicius S, Diaz R, Eikelboom JW, Fox KA, Granger CB, Jolly S, Joyner CD, Rupprecht HJ, Widimsky P, Afzal R, Pogue J, Yusuf S.

N Engl J Med. 2010 Sep 2;363(10):930-42. doi: 10.1056/NEJMoa0909475. Erratum in: N Engl J Med. 2010 Oct 14;363(16):1585.

Supplemental Content

Loading ...
Support Center